During the past decade, Breast Cancer Research Centre - WA conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Breast Cancer Research Centre - WA" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Alliance Foundation Trials, LLC." with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Breast Cancer Research Centre - WA" #1 collaborator was "NSABP Foundation Inc" with 3 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "PrECOG, LLC." with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Breast Cancer Research Centre - WA" are "Breast Cancer" (5 trials), "Triple Negative Breast Cancer" (3 trials), "Advanced Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Breast Cancer Research Centre - WA" in a lesser frequency.

Most popular intervention types in "Breast Cancer Research Centre - WA" are "Drug" (11 trials), "Biological" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anastrozole" (3 trials), "Abemaciclib" (2 trials), "Carboplatin" (2 trials), "Exemestane" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Breast Cancer Research Centre - WA" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Breast Cancer Research Centre - WA". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Breast Cancer Research Centre - WA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Breast Cancer Research Centre - WA, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".